BRAIN Biotech AG (LON:0RFI)

BRAIN Biotech AG Statistics

Total Valuation

LON:0RFI has a market cap or net worth of GBP 36.84 million. The enterprise value is 28.95 million.

Market Cap	36.84M
Enterprise Value	28.95M

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	21.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.82
PB Ratio	6.12
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.53
EV / Sales	0.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.18

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.64.

Current Ratio	1.85
Quick Ratio	1.22
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	-0.69
Interest Coverage	-2.70

Financial Efficiency

Return on equity (ROE) is -102.10% and return on invested capital (ROIC) is -32.59%.

Return on Equity (ROE)	-102.10%
Return on Assets (ROA)	-8.42%
Return on Invested Capital (ROIC)	-32.59%
Return on Capital Employed (ROCE)	-17.05%
Revenue Per Employee	157,089
Profits Per Employee	-40,091
Employee Count	318
Asset Turnover	0.70
Inventory Turnover	2.55

Taxes

Income Tax	-197,429
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.76%
50-Day Moving Average	2.37
200-Day Moving Average	3.14
Relative Strength Index (RSI)	39.57
Average Volume (20 Days)	102

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RFI had revenue of GBP 44.77 million and -11.43 million in losses. Loss per share was -0.52.

Revenue	44.77M
Gross Profit	24.36M
Operating Income	-8.58M
Pretax Income	-11.64M
Net Income	-11.43M
EBITDA	-5.75M
EBIT	-8.58M
Loss Per Share	-0.52

Balance Sheet

The company has 12.44 million in cash and 3.84 million in debt, giving a net cash position of 8.60 million.

Cash & Cash Equivalents	12.44M
Total Debt	3.84M
Net Cash	8.60M
Net Cash Per Share	n/a
Equity (Book Value)	6.02M
Book Value Per Share	0.23
Working Capital	13.39M

Cash Flow

In the last 12 months, operating cash flow was -4.47 million and capital expenditures -1.11 million, giving a free cash flow of -5.58 million.

Operating Cash Flow	-4.47M
Capital Expenditures	-1.11M
Free Cash Flow	-5.58M
FCF Per Share	n/a

Margins

Gross margin is 54.42%, with operating and profit margins of -19.18% and -25.52%.

Gross Margin	54.42%
Operating Margin	-19.18%
Pretax Margin	-26.00%
Profit Margin	-25.52%
EBITDA Margin	-12.83%
EBIT Margin	-19.18%
FCF Margin	n/a

Dividends & Yields

LON:0RFI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-31.02%
FCF Yield	-15.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RFI has an Altman Z-Score of -1.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.02
Piotroski F-Score	1